Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony O'hagan

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Pharmaceutical Statistics|September 20, 2011
Designing a non-inferiority study in kidney transplantation: a case studySteffen Witte, Heinz Schmidli, Anthony O'Hagan, et al.
Statistics in Medicine|March 9, 2010
A comparison of United States and United Kingdom EQ-5D health states valuations using a nonparametric Bayesian methodSamer A Kharroubi, Anthony O'Hagan, John E Brazier
Health Economics|August 28, 2010
Review of statistical methods for analysing healthcare resources and costsBorislava Mihaylova, Andrew Briggs, Anthony O'Hagan, et al.
Journal of Health Economics|October 31, 2006
Modelling SF-6D health state preference data using a nonparametric Bayesian methodSamer A Kharroubi, John E Brazier, Jennifer Roberts, et al.
The American Statistician|May 7, 2019
The Role of Expert Judgment in Statistical Inference and Evidence-Based Decision-MakingNaomi C Brownstein, Thomas A Louis, Anthony O'Hagan, et al.
Pharmacoeconomics|March 12, 2003
The cost effectiveness of two new antiepileptic therapies in the absence of direct comparative data: a first approximationBen A van Hout, Dennis D Gagnon, Pauline McNulty, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 8, 2012
Inverse probability weighted least squares regression in the analysis of time-censored cost data: an evaluation of the approach using SEER-MedicareRobert I Griffiths, Michelle L Gleeson, Mark D Danese, et al.
Biometrics|October 31, 2014
Robust meta-analytic-predictive priors in clinical trials with historical control informationHeinz Schmidli, Sandro Gsteiger, Satrajit Roychoudhury, et al.
European Child & Adolescent Psychiatry|April 7, 2021
Response (minimum clinically relevant change) in ASD symptoms after an intervention according to CARS-2: consensus from an expert elicitation procedureLucie Jurek, Matias Baltazar, Sheffali Gulati, et al.
Environmental Science & Technology|January 26, 2006
Bayesian and time-independent species sensitivity distributions for risk assessment of chemicalsEric P M Grist, Anthony O'Hagan, Mark Crane, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Pharmaceutical Statistics|September 20, 2011
Designing a non-inferiority study in kidney transplantation: a case studySteffen Witte, Heinz Schmidli, Anthony O'Hagan, et al.
Statistics in Medicine|March 9, 2010
A comparison of United States and United Kingdom EQ-5D health states valuations using a nonparametric Bayesian methodSamer A Kharroubi, Anthony O'Hagan, John E Brazier
Health Economics|August 28, 2010
Review of statistical methods for analysing healthcare resources and costsBorislava Mihaylova, Andrew Briggs, Anthony O'Hagan, et al.
Journal of Health Economics|October 31, 2006
Modelling SF-6D health state preference data using a nonparametric Bayesian methodSamer A Kharroubi, John E Brazier, Jennifer Roberts, et al.
The American Statistician|May 7, 2019
The Role of Expert Judgment in Statistical Inference and Evidence-Based Decision-MakingNaomi C Brownstein, Thomas A Louis, Anthony O'Hagan, et al.
Pharmacoeconomics|March 12, 2003
The cost effectiveness of two new antiepileptic therapies in the absence of direct comparative data: a first approximationBen A van Hout, Dennis D Gagnon, Pauline McNulty, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 8, 2012
Inverse probability weighted least squares regression in the analysis of time-censored cost data: an evaluation of the approach using SEER-MedicareRobert I Griffiths, Michelle L Gleeson, Mark D Danese, et al.
Biometrics|October 31, 2014
Robust meta-analytic-predictive priors in clinical trials with historical control informationHeinz Schmidli, Sandro Gsteiger, Satrajit Roychoudhury, et al.
European Child & Adolescent Psychiatry|April 7, 2021
Response (minimum clinically relevant change) in ASD symptoms after an intervention according to CARS-2: consensus from an expert elicitation procedureLucie Jurek, Matias Baltazar, Sheffali Gulati, et al.
Environmental Science & Technology|January 26, 2006
Bayesian and time-independent species sensitivity distributions for risk assessment of chemicalsEric P M Grist, Anthony O'Hagan, Mark Crane, et al.
Pageof 3